Beth Israel Deaconess Medical Center, an academic medical center affiliated with Harvard Medical School, Dana-Farber Cancer Institute and the Boston Red Sox, operates 766 licensed beds and handles more than 4,600 births, 39,000 inpatient discharges, 55,000 emergency department visits and 760,000 outpatient visits each year. The medical center is part of Cambridge, Mass.-based Beth Israel Lahey Health, a system spanning academic medical centers, teaching hospitals, and community and specialty hospitals with more than 4,700 physicians and 39,000 employees. U.S. News & World Report’s 2026-2027 “Best Hospitals” rankings placed Beth Israel Deaconess Medical Center as the No. 3 hospital in both the Boston metro area and Massachusetts. The medical center ranked among the nation’s top 50 hospitals in eight specialties, including No.4 in obstetrics and gynecology, No. 9 in diabetes and endocrinology, No. 26 in gastroenterology and GI surgery and No. 28 in cancer care. The medical center’s research enterprise includes more than 250 principal investigators, who are all Harvard Medical School faculty, leading more than 2,500 active sponsored projects. The medical center draws more than $300 million in annual research funding, consistently ranking among the nation’s top independent hospitals for National Institutes of Health support. The medical center’s findings regularly appear in leading journals including Nature, Science, Cell and The New England Journal of Medicine.
